AzTrials
AzTrials

Spinal Cord Injury CervicalNCT07225582

Development of Optimal Sensory Feedback Strategies to Maximize Function After Tetraplegia

A study testing Brain Computer Interface (BCI) - Functional Electrical Stimulation (FES) system in people with Spinal Cord Injury Cervical and Spinal Cord Injuries (Complete and Incomplete), run by Case Western Reserve University at 1 site in United States.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The goal of this clinical trial is to learn more about how stimulating the nerves involved in sensation (either in the limbs or in the brain) can be used to restore sensation in participants who have a spinal cord injury. Read more about this study

Who is it for?
Ages 22 to 65 years
What is being tested?
Brain Computer Interface (BCI) - Functional Electrical Stimulation (FES) system
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
3 participants
Where
1 siteUnited States
Study dates
13 Jan 2026to 1 Sep 2030
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 22 to 65 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Enrolled in the ReHAB clinical trial and received ReHAB system components via implantation surgery.
  • Willingness and availability to follow the study protocol.

Who cannot join

  • Lack of function or operability of all implanted ReHAB system components
  • Severe pain or other chronic medical condition that would prevent the participant from completing study-related activities

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Emily Graczyk, Ph.D. contact

216.368.5182

elg46@case.edu

United States1 site, 1 recruiting
  • Case Western Reserve University

    Cleveland, Ohio, 44106

    Emily Graczyk, Ph.D., 216-368-5182, emily.graczyk@case.edu

    Emily Graczyk, Ph.D.

    Recruiting

Other trials in United States

About this study

Official title: Development of Optimal Sensory Feedback Strategies to Maximize Function After Tetraplegia: A Sub-study of the Reconnecting the Hand and Arm to the Brain (ReHAB) Clinical Trial

The goal of this clinical trial is to learn more about how stimulating the nerves involved in sensation (either in the limbs or in the brain) can be used to restore sensation in participants who have a spinal cord injury. Participants in this study will have already been enrolled in the "Reconnecting the Hand and Arm to the Brain (ReHAB)" study, and received small electrodes in a part of the brain that is involved in sensing touch and pressure in the hand. The ReHAB study participants will also have received electrodes around the nerves in their arm. In this clinical trial, participants will receive two types of electrical stimulation:

  • Intracortical microstimulation (ICMS) which involves sending small electrical pulses to the part of the brain that processes sensation.
  • Peripheral nerve stimulation (PNS) which involves sending small electrical pulses to the nerves in the arm that transmit sensations from the hand.

Researchers will try different patterns of stimulation for both ICMS and PNS and study how the participants perceive the sensations from the different stimulation patterns. The researchers will also study how combining ICMS and PNS affects the perceived sensations.

Read the detailed description

The overall goal of this study is to compare the sensations that are perceived from intracortical microstimulation (ICMS) to those perceived from peripheral nerve stimulation (PNS), and also to perceived sensations from a combination of ICMS and PNS.

Preceding study

Participants for this study will be individuals with a high-level spinal cord injury who are already enrolled in the "Reconnecting the Hand and Arm to the Brain (ReHAB)" clinical trial (ID# NCT03898804). The ReHAB clinical trial involves receiving tiny electrode arrays in the brain and small electrodes around some of the nerves in the arm. The goal of the ReHAB clinical trial is to restore arm and hand movement and sensation in individuals with paralysis from a spinal cord injury.

Goals of this clinical trial

The purpose of the proposed study is to investigate the perception and functional impact of sensory neurostimulation in participants with tetraplegia. Investigators will develop and implement novel paradigms of ICMS applied to primary somatosensory cortex (S1) and PNS applied to upper extremity nerves through chronically-implanted cuff electrodes. Investigators will also develop and assess hybrid neurostimulation paradigms involving paired application of ICMS and PNS. For each paradigm, investigators will quantify the perceived sensation with classic psychophysical methods. Investigators will also implement the approach into closed-loop tasks in virtual reality controlled through decoded cortical signals recorded from intracortical microelectrode arrays. Finally, investigators will assess the impact of each stimulation paradigm on residual sensory function.

In Aim 1, investigators will develop a novel ICMS paradigm that attempts to reproduce both the temporal and spatial activation patterns that occur in S1 during normal touch. Investigators will compare this novel paradigm to other existing ICMS encoders. Investigators will assess the impact of each ICMS encoder on perceptual response, task performance in virtual reality (VR), and residual sensory function. In Aim 2, investigators will develop novel PNS paradigms and assess the efficacy of PNS for sensory feedback in people with tetraplegia for the first time. As in Aim 1, investigators will develop and compare several PNS encoders, including those that reproduce aspects of the peripheral response to normal touch and traditional linear encoders. We will assess the impact of each PNS encoder on perceptual response, task performance in VR, and residual sensory function. In Aim 3, we will develop hybrid neurostimulation paradigms that pair ICMS with PNS. We will assess the impact of stimulation encoder and stimulation amplitude on the perceived sensations generated by hybrid stimulation. We will then investigate the impact of PNS-ICMS timing delays within the hybrid neurostimulation paradigm on the perceptual response, functional impact, and impact on residual sensory function.

All participants will participate in all aims and will receive all stimulation approaches and perform all tasks and measures. All participants will serve as their own control for the planned statistical analyses. The study will generate tens of thousands of perceptual response data points, hundreds of functional task data points, and hundreds of thousands of intracortical recordings (for exploratory analyses).

Being tested
Brain Computer Interface (BCI) - Functional Electrical Stimulation (FES) system
Keywords
spinal cord injury, tetraplegia, intracortical microstimulation, peripheral nerve stimulation
Medical subject headings
Spinal Cord Injuries, Quadriplegia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Brain Computer Interface (BCI) - Functional Electrical Stimulation (FES) systemDevice

    Participants with tetraplegia who have received intracortical arrays in the sensory cortex and peripheral nerve cuff electrodes will undergo a variety of stimulation paradigms to investigate the perception and functional impact of sensory neurostimulation.

Study groups in NCT07225582
Study groupRoleWhat they receive
Intracortical microstimulation and peripheral nerve stimulation for people with tetraplegiaExperimentalThe purpose of the proposed study is to investigate the perception and functional impact of sensory neurostimulation in participants with tetraplegia. Investigators will develop and implement novel paradigms of intracortical microstimulation (ICMS) applied to primary somatosensory cortex (S1) and peripheral nerve stimulation (PNS) applied to upper extremity nerves through chronically-implanted cuff electrodes. Investigators will also develop and assess hybrid neurostimulation paradigms involving paired application of ICMS and PNS. For each paradigm, investigators will quantify the perceived sensation with classic psychophysical methods. Investigators will also implement the approach into closed-loop tasks in virtual reality controlled through decoded cortical signals recorded from intracortical microelectrode arrays. Finally, investigators will assess the impact of each stimulation paradigm on residual sensory function.
Receives: Device: Brain Computer Interface (BCI) - Functional Electrical Stimulation (FES) system

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Force matching success rate

    Percentage of force matching trials per block in which the target force was achieved before the time limit

    Measured: From enrollment to around two years after enrollment

  2. Object discrimination accuracy

    Percentage of trials per block in which the correct object was identified

    Measured: From enrollment to around two years after enrollment

  3. Discrimination threshold

    Minimal change in stimulation that results in a reliably distinguishable change in perceived magnitude

    Measured: From enrollment until around two years post-enrollment

  4. Tactor detection threshold

    Minimal mechanical stimulus, delivered by a tactor that the participant can reliably perceive

    Measured: From enrollment to around two years after enrollment

Secondary outcomes (7)
  1. Sensory dynamic range

    Difference in minimum and maximum stimulation levels that elicit detectable, comfortable sensation

    Measured: From enrollment until around two years post-enrollment

  2. Projected field location

    The position of the sensory percept reported on a hand/arm diagram

    Measured: From enrollment until around two years post-enrollment

  3. Sensation quality

    The participant's description of the quality of the sensation evoked by stimulation, reported as a selection of descriptor words

    Measured: From enrollment to around two years after enrollment

  4. Naturalness rating

    The participant's rating of the perceived naturalness of the stimulus on an open-ended scale

    Measured: From enrollment until around two years post-enrollment

  5. Tactor discrimination threshold

    Minimal change in mechanical touch input that results in a reliably distinguishable change in perceived magnitude

    Measured: From enrollment to around two years after enrollment

  6. Force matching time to target

    The time elapsed from the go cue required for the participant to hit the force target

    Measured: From enrollment to around two years after enrollment

  7. Posture matching success rate

    Percentage of posture matching trials per block in which the target posture was achieved before the time limit

    Measured: From enrollment to around two years after enrollment

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted6 Nov 2025
  2. Study start13 Jan 2026
  3. Primary completion1 Sep 2030 (estimated)
  4. Study completion1 Sep 2030 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Device feasibility
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
3 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07225582
Sponsor's protocol ID
STUDY20190226
Other IDs
R01HD117313
Status last verified
Feb 2026
First submitted
4 Nov 2025
Last updated
19 Feb 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
Yes
Individual data sharing
Yes: IPD may be shared for publications.

Questions about this trial

What is this clinical trial studying?

A study testing Brain Computer Interface (BCI) - Functional Electrical Stimulation (FES) system in people with Spinal Cord Injury Cervical and Spinal Cord Injuries (Complete and Incomplete), run by Case Western Reserve University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 19 Feb 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Emily Graczyk, Ph.D. (216.368.5182, elg46@case.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Force matching success rate (time frame: From enrollment to around two years after enrollment). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Feb 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in